Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2080466)

Published in Croat Med J on October 01, 2006

Authors

Vaneja Velenik1, Franc Anderluh, Irena Oblak, Primoz Strojan, Branko Zakotnik

Author Affiliations

1: Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia. vvelenik@onko-i.si

Associated clinical trials:

Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study (CRAB) | NCT00842686

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer (XERT) | NCT00689702

Articles cited by this

Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68

Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med (1997) 9.99

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer (1998) 5.40

Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol (1997) 4.43

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys (2000) 3.47

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol (2000) 3.04

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol (1998) 2.27

Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol (2002) 2.23

Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum (1998) 2.09

A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum (1997) 1.58

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur J Cancer (2001) 1.52

Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2002) 1.29

Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2005) 1.22

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int J Radiat Oncol Biol Phys (2002) 1.11

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine. Bioorg Med Chem (2000) 1.10

Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin. Semin Oncol (1997) 0.92

Fluoropyrimidine-Radiation Interactions in Cells and Tumors. Semin Radiat Oncol (1997) 0.91

Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands. Clin Ther (2004) 0.89

Irradiation Plus 5-Fluorouracil: Cellular Mechanisms of Action and Treatment Schedules. Semin Radiat Oncol (1997) 0.80

Articles by these authors

Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13

Radiotherapy for perianal Paget's disease: a case report. Tumori (2008) 1.02

Long term outcome after combined modality treatment for anal cancer. Radiol Oncol (2012) 1.02

Fertility in patients treated for testicular cancer. J Cancer Surviv (2010) 0.96

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study. Radiat Oncol (2011) 0.92

Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin. Int J Radiat Oncol Biol Phys (2006) 0.92

Digital ischemic events related to gemcitabine: Report of two cases and a systematic review. Radiol Oncol (2010) 0.89

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiat Oncol (2010) 0.89

The first survival score for patients with brain metastases from small cell lung cancer (SCLC). Clin Neurol Neurosurg (2013) 0.87

Dumbbell synovial sarcoma of the thoracolumbar spine: a case report. Spine (Phila Pa 1976) (2009) 0.87

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer. Radiol Oncol (2013) 0.85

Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial. Radiol Oncol (2012) 0.85

Sinonasal inverted papilloma associated with squamous cell carcinoma. Radiol Oncol (2011) 0.85

Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study. Clin Nutr (2011) 0.85

Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2003) 0.84

Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma. Pharmacogenet Genomics (2014) 0.83

concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study. Int J Radiat Oncol Biol Phys (2008) 0.83

Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy. Biomed Eng Online (2015) 0.83

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III. Radiol Oncol (2011) 0.81

Image cytometric nuclear texture features in inoperable head and neck cancer: a pilot study. Radiol Oncol (2011) 0.81

Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study. Radiother Oncol (2009) 0.79

Contemporary management of sinonasal cancer. Head Neck (2010) 0.78

Easing acceleration of head and neck chemoradiotherapy. Lancet Oncol (2012) 0.78

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia. Radiol Oncol (2012) 0.78

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin. Radiol Oncol (2016) 0.77

Intraarterial chemotherapy: a valid option in the treatment of verrucous carcinoma? Eur Arch Otorhinolaryngol (2010) 0.77

Risk factors for voice quality after radiotherapy for early glottic cancer. Radiother Oncol (2009) 0.76

Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients. OMICS (2015) 0.76

Mental disorders after laryngectomy. Onkologie (2005) 0.76

Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer (2010) 0.75

Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer. J Thorac Oncol (2006) 0.75

Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer. Head Neck (2013) 0.75

Computed tomography perfusion assessment of radiation therapy effects on spinal cord hemodynamics. Int J Radiat Oncol Biol Phys (2009) 0.75

Schedule-dependent interaction between vinblastine and irradiation in experimental sarcoma. Strahlenther Onkol (2014) 0.75

TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. Head Neck (2013) 0.75

Successful therapy of choroid plexus carcinoma. Pediatr Blood Cancer (2004) 0.75